HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nagahisa Yoshimura Selected Research

Polypoidal Choroidal Vasculopathy

3/2018Baseline data from a multicenter, 5-year, prospective cohort study of Japanese age-related macular degeneration: an AMD2000 report.
12/2017HDL-cholesterol levels and risk of age-related macular degeneration: a multiethnic genetic study using Mendelian randomization.
9/2015Effects of aflibercept for ranibizumab-resistant neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
5/2015One-year result of aflibercept treatment on age-related macular degeneration and predictive factors for visual outcome.
2/2015Two-year visual outcome of ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
2/2015Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab.
9/2013Association between the cholesteryl ester transfer protein gene and polypoidal choroidal vasculopathy.
5/2013Intravitreal injection of ranibizumab for recovery of macular function in eyes with subfoveal polypoidal choroidal vasculopathy.
4/2013Two-year outcome of photodynamic therapy combined with intravitreal injection of bevacizumab and triamcinolone acetonide for polypoidal choroidal vasculopathy.
2/2013Prevalence and genomic association of reticular pseudodrusen in age-related macular degeneration.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nagahisa Yoshimura Research Topics

Disease

43Macular Degeneration (Age-Related Maculopathy)
01/2021 - 10/2004
37Macular Edema
01/2019 - 04/2005
36Polypoidal Choroidal Vasculopathy
03/2018 - 05/2002
35Glaucoma
02/2018 - 10/2003
27Diabetic Retinopathy (Retinopathy, Diabetic)
01/2021 - 09/2004
21Retinal Vein Occlusion
02/2018 - 08/2006
20Choroidal Neovascularization
03/2018 - 05/2006
19Ganglion Cysts (Ganglion)
01/2017 - 02/2002
16Retinal Detachment (Retinal Detachments)
05/2014 - 11/2002
15Myopia
11/2016 - 08/2008
12Retinitis Pigmentosa (Pigmentary Retinopathy)
02/2018 - 01/2012
11Hemorrhage
03/2017 - 05/2006
10Epiretinal Membrane (Epiretinal Membranes)
04/2019 - 01/2009
9Open-Angle Glaucoma (Glaucoma, Open Angle)
10/2017 - 10/2010
9Retinal Perforations
04/2013 - 04/2007
8Atrophy
01/2018 - 08/2008
7Retinal Degeneration
02/2018 - 01/2007
7Vitreous Hemorrhage
07/2015 - 09/2005
7Central Serous Chorioretinopathy
03/2011 - 11/2007
7Ischemia
08/2007 - 02/2002
5Eye Diseases (Eye Disease)
02/2018 - 08/2014
5Retinal Diseases
01/2017 - 02/2008
5Inflammation (Inflammations)
01/2017 - 03/2002
5Cataract (Cataracts)
05/2016 - 04/2011
5Retinal Neovascularization
08/2007 - 09/2004
4Bietti Crystalline Dystrophy
10/2018 - 03/2012
4Disease Progression
05/2018 - 02/2010
4Neurodegenerative Diseases (Neurodegenerative Disease)
02/2018 - 06/2008
4Reperfusion Injury
09/2006 - 02/2002
4Uveitis
03/2005 - 03/2002
3Blindness (Hysterical Blindness)
02/2018 - 01/2012
3Vision Disorders (Hemeralopia)
02/2017 - 05/2011
3Geographic Atrophy
01/2016 - 02/2013
3Exfoliation Syndrome
11/2015 - 03/2008
3Scotoma (Scintillating Scotoma)
11/2013 - 05/2009
3Telangiectasis (Telangiectasia)
06/2013 - 07/2011
3Angioid Streaks
04/2013 - 05/2010
2Wounds and Injuries (Trauma)
01/2019 - 08/2003
2Type 2 Diabetes Mellitus (MODY)
01/2019 - 01/2017
2Neuroinflammatory Diseases
01/2019 - 11/2012
2Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
01/2017 - 01/2014
2Hypertension (High Blood Pressure)
12/2015 - 02/2007
2Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
05/2014 - 01/2011
2Malignant Hypertension
01/2014 - 08/2012
2White Dot Syndromes
01/2014 - 10/2009
2Neoplasms (Cancer)
08/2013 - 09/2008
2Microaneurysm
04/2013 - 02/2011
2Vitreous Detachment (Posterior Vitreous Detachment)
01/2013 - 10/2007
2Papilledema
07/2012 - 04/2005
2Blister (Bulla)
08/2010 - 12/2007

Drug/Important Bio-Agent (IBA)

117Retinaldehyde (Retinal)IBA
01/2021 - 02/2002
19Fluorescein (Funduscein)FDA LinkGeneric
03/2018 - 09/2007
17Ranibizumab (Lucentis)FDA Link
05/2018 - 01/2012
16Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 09/2004
13Indocyanine Green (Cardio-Green)FDA LinkGeneric
03/2018 - 06/2004
131-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2015 - 05/2006
11Bevacizumab (Avastin)FDA Link
04/2013 - 05/2009
9afliberceptIBA
01/2021 - 11/2014
8Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
01/2019 - 02/2007
8Retinal Pigments (Pigments, Visual)IBA
01/2018 - 02/2002
8Complement Factor H (Factor H)IBA
12/2017 - 08/2006
5LipidsIBA
10/2018 - 03/2011
4Neuroprotective AgentsIBA
01/2020 - 02/2002
4KUS121IBA
01/2020 - 01/2016
4Proteins (Proteins, Gene)FDA Link
08/2018 - 06/2002
4DNA (Deoxyribonucleic Acid)IBA
01/2016 - 03/2005
4SteroidsIBA
09/2014 - 10/2003
4CytokinesIBA
08/2012 - 03/2002
4Tissue Plasminogen Activator (Alteplase)FDA Link
04/2009 - 08/2006
4EndotoxinsIBA
03/2005 - 03/2002
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021 - 01/2018
3Biomarkers (Surrogate Marker)IBA
01/2019 - 01/2017
3Adenosine Triphosphate (ATP)IBA
05/2018 - 08/2014
3Triamcinolone (Aristocort)FDA Link
02/2015 - 01/2009
3FibrinIBA
08/2012 - 08/2010
3Adrenal Cortex Hormones (Corticosteroids)IBA
09/2008 - 11/2002
2AutoantibodiesIBA
01/2019 - 08/2013
2Branched-Chain Amino AcidsIBA
02/2018 - 01/2018
2HDL CholesterolIBA
12/2017 - 01/2015
2HDL LipoproteinsIBA
11/2017 - 04/2010
2Rhodopsin (Visual Purple)IBA
01/2016 - 01/2012
2ras-GRF1 (ras GRF1)IBA
10/2014 - 11/2013
2Coloring Agents (Dyes)IBA
12/2013 - 09/2009
2pigment epithelium-derived factorIBA
06/2013 - 07/2011
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2011 - 06/2008
2Verteporfin (Visudyne)FDA Link
05/2010 - 09/2008
2ErythropoietinFDA Link
06/2008 - 08/2005

Therapy/Procedure

28Lasers (Laser)
10/2017 - 10/2003
18Intravitreal Injections
01/2017 - 04/2005
16Vitrectomy
01/2018 - 11/2002
16Photochemotherapy (Photodynamic Therapy)
02/2015 - 05/2006
13Therapeutics
01/2021 - 10/2003
7Injections
02/2018 - 01/2012
6Trabeculectomy (Trabeculoplasty)
01/2017 - 08/2010
5Traction
05/2016 - 04/2007
4Aftercare (After-Treatment)
02/2018 - 01/2011
4Light Coagulation
01/2011 - 10/2003
2Phacoemulsification
05/2016 - 01/2014
2Iridectomy
01/2014 - 10/2003
2Endoscopes
07/2011 - 09/2005